Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Herrmann

Showing results (121-130 of 470) with videos related to

Pageof 47
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 30, 2008
Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysisElmira Valiyeva, Nathan Herrmann, Paula A Rochon, et al.
International Journal of Geriatric Psychiatry|July 12, 2002
Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's diseaseKrista L Lanctôt, Nathan Herrmann, Robert van Reekum, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 13, 2006
Predictors of driving cessation in mild-to-moderate dementiaNathan Herrmann, Mark J Rapoport, Robert Sambrook, et al.
International Psychogeriatrics|March 21, 2007
Panic disorder in later life: results from a national survey of CanadiansLaurie M Corna, John Cairney, Nathan Herrmann, et al.
Journal of Clinical Psychopharmacology|November 12, 2005
Antidepressants, warfarin, and the risk of hemorrhagePaul A Kurdyak, David N Juurlink, Alexander Kopp, et al.
Neuropsychiatric Disease and Treatment|October 23, 2015
A meta-analysis of lipid peroxidation markers in major depressionGraham Mazereeuw, Nathan Herrmann, Ana C Andreazza, et al.
The Cochrane Database of Systematic Reviews|May 5, 2018
Pharmacological interventions for apathy in Alzheimer's diseaseMyuri T Ruthirakuhan, Nathan Herrmann, Eleenor H Abraham, et al.
Neurodegenerative Disease Management|July 25, 2018
Psychometric properties of apathy scales in Parkinson's disease: a systematic reviewDana Mohammad, Courtney Ellis, Allison Rau, et al.
International Psychogeriatrics|April 5, 2018
Correlates of nursing care burden among institutionalized patients with dementiaMeng Sun, Brian J Mainland, Tisha J Ornstein, et al.
CNS Drugs|August 15, 2015
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's DiseaseCelina S Liu, Sarah A Chau, Myuri Ruthirakuhan, et al.
Pageof 47

Showing results (121-130 of 470) with videos related to

Sort By:
Pageof 47
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 30, 2008
Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysisElmira Valiyeva, Nathan Herrmann, Paula A Rochon, et al.
International Journal of Geriatric Psychiatry|July 12, 2002
Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's diseaseKrista L Lanctôt, Nathan Herrmann, Robert van Reekum, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 13, 2006
Predictors of driving cessation in mild-to-moderate dementiaNathan Herrmann, Mark J Rapoport, Robert Sambrook, et al.
International Psychogeriatrics|March 21, 2007
Panic disorder in later life: results from a national survey of CanadiansLaurie M Corna, John Cairney, Nathan Herrmann, et al.
Journal of Clinical Psychopharmacology|November 12, 2005
Antidepressants, warfarin, and the risk of hemorrhagePaul A Kurdyak, David N Juurlink, Alexander Kopp, et al.
Neuropsychiatric Disease and Treatment|October 23, 2015
A meta-analysis of lipid peroxidation markers in major depressionGraham Mazereeuw, Nathan Herrmann, Ana C Andreazza, et al.
The Cochrane Database of Systematic Reviews|May 5, 2018
Pharmacological interventions for apathy in Alzheimer's diseaseMyuri T Ruthirakuhan, Nathan Herrmann, Eleenor H Abraham, et al.
Neurodegenerative Disease Management|July 25, 2018
Psychometric properties of apathy scales in Parkinson's disease: a systematic reviewDana Mohammad, Courtney Ellis, Allison Rau, et al.
International Psychogeriatrics|April 5, 2018
Correlates of nursing care burden among institutionalized patients with dementiaMeng Sun, Brian J Mainland, Tisha J Ornstein, et al.
CNS Drugs|August 15, 2015
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer's DiseaseCelina S Liu, Sarah A Chau, Myuri Ruthirakuhan, et al.
Pageof 47